These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 15950015

  • 1. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.
    Volkow ND, Wang GJ, Fowler JS, Ding YS.
    Biol Psychiatry; 2005 Jun 01; 57(11):1410-5. PubMed ID: 15950015
    [Abstract] [Full Text] [Related]

  • 2. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE.
    J Clin Psychopharmacol; 2008 Jun 01; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [Abstract] [Full Text] [Related]

  • 3. Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study.
    Ludolph AG, Kassubek J, Schmeck K, Glaser C, Wunderlich A, Buck AK, Reske SN, Fegert JM, Mottaghy FM.
    Neuroimage; 2008 Jul 01; 41(3):718-27. PubMed ID: 18424180
    [Abstract] [Full Text] [Related]

  • 4. [Alterations in the pattern of dopaminergic markers in attention-deficit/hyperactivity disorder].
    Díaz-Heijtz R, Mulas F, Forssberg H.
    Rev Neurol; 2006 Feb 13; 42 Suppl 2():S19-23. PubMed ID: 16555214
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of action of methylphenidate: insights from PET imaging studies.
    Volkow ND, Fowler JS, Wang G, Ding Y, Gatley SJ.
    J Atten Disord; 2002 Feb 13; 6 Suppl 1():S31-43. PubMed ID: 12685517
    [Abstract] [Full Text] [Related]

  • 6. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder.
    Rosa-Neto P, Lou HC, Cumming P, Pryds O, Karrebaek H, Lunding J, Gjedde A.
    Neuroimage; 2005 Apr 15; 25(3):868-76. PubMed ID: 15808987
    [Abstract] [Full Text] [Related]

  • 7. Early stress and chronic methylphenidate cross-sensitize dopaminergic responses in the adolescent medial prefrontal cortex and nucleus accumbens.
    Jezierski G, Zehle S, Bock J, Braun K, Gruss M.
    J Neurochem; 2007 Dec 15; 103(6):2234-44. PubMed ID: 17924950
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine.
    Schiffer WK, Volkow ND, Fowler JS, Alexoff DL, Logan J, Dewey SL.
    Synapse; 2006 Mar 15; 59(4):243-51. PubMed ID: 16385551
    [Abstract] [Full Text] [Related]

  • 9. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.
    Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, Ding YS, Gatley SJ, Gifford A, Zhu W, Swanson JM.
    Synapse; 2002 Mar 01; 43(3):181-7. PubMed ID: 11793423
    [Abstract] [Full Text] [Related]

  • 10. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
    Fone KC, Nutt DJ.
    Curr Opin Pharmacol; 2005 Feb 01; 5(1):87-93. PubMed ID: 15661631
    [Abstract] [Full Text] [Related]

  • 11. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.
    Augustyniak PN, Kourrich S, Rezazadeh SM, Stewart J, Arvanitogiannis A.
    Behav Brain Res; 2006 Feb 28; 167(2):379-82. PubMed ID: 16246436
    [Abstract] [Full Text] [Related]

  • 12. Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry.
    Teicher MH, Anderson CM, Polcari A, Glod CA, Maas LC, Renshaw PF.
    Nat Med; 2000 Apr 28; 6(4):470-3. PubMed ID: 10742158
    [Abstract] [Full Text] [Related]

  • 13. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder.
    Staller JA, Faraone SV.
    Expert Rev Neurother; 2007 Apr 28; 7(4):351-62. PubMed ID: 17425490
    [Abstract] [Full Text] [Related]

  • 14. The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder.
    Han DH, Lee YS, Na C, Ahn JY, Chung US, Daniels MA, Haws CA, Renshaw PF.
    Compr Psychiatry; 2009 Apr 28; 50(3):251-6. PubMed ID: 19374970
    [Abstract] [Full Text] [Related]

  • 15. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
    Bush G, Spencer TJ, Holmes J, Shin LM, Valera EM, Seidman LJ, Makris N, Surman C, Aleardi M, Mick E, Biederman J.
    Arch Gen Psychiatry; 2008 Jan 28; 65(1):102-14. PubMed ID: 18180434
    [Abstract] [Full Text] [Related]

  • 16. Methylphenidate HCl: therapy for attention deficit hyperactivity disorder.
    Capp PK, Pearl PL, Conlon C.
    Expert Rev Neurother; 2005 May 28; 5(3):325-31. PubMed ID: 15938665
    [Abstract] [Full Text] [Related]

  • 17. The neuropsychopharmacology of attention-deficit/hyperactivity disorder.
    Pliszka SR.
    Biol Psychiatry; 2005 Jun 01; 57(11):1385-90. PubMed ID: 15950012
    [Abstract] [Full Text] [Related]

  • 18. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ, Merkel RL, Moore M, Thorndike F, Muller C, Kovatchev B.
    Pediatrics; 2006 Sep 01; 118(3):e704-10. PubMed ID: 16950962
    [Abstract] [Full Text] [Related]

  • 19. OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.
    Ramos-Quiroga JA, Corominas M, Castells X, Bosch R, Casas M.
    Expert Rev Neurother; 2009 Aug 01; 9(8):1121-31. PubMed ID: 19673602
    [Abstract] [Full Text] [Related]

  • 20. Study supports medication for ADHD.
    Health News; 2000 Feb 01; 6(2):5. PubMed ID: 10734823
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.